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Abstract
Background: Although interventions in childbirth are important in order to prevent neonatal and maternal morbidity
and mortality, non-indicated use may cause avoidable harm. Regional variations in intervention rates, which cannot be
explained by maternal characteristics, may indicate over- and underuse. The aim of this study is to explore
regional variations in childbirth interventions in the Netherlands and their associations with interventions
and adverse outcomes, controlled for maternal characteristics.
Methods: Childbirth intervention rates were compared between twelve Dutch regions, using data from the
national perinatal birth register for 2010–2013. All single childbirths from 37 weeks’ gestation onwards were
included. Primary outcomes were induction and augmentation of labour, pain medication, instrumental birth,
caesarean section (prelabour, intrapartum) and paediatric involvement. Secondary outcomes were adverse neonatal and
maternal outcomes. Multivariable logistic regression analyses were used to adjust for maternal characteristics. Associations
were expressed in Spearman’s rank correlation coefficients.
Results: Most variation was found for type of pain medication and paediatric involvement. Epidural analgesia rates varied
from between 12 and 38% (nulliparous) and from between 5 and 14% (multiparous women). These rates were negatively
correlated with rates of other pharmacological pain relief, which varied from between 15 and 43% (nulliparous) and from
between 10 and 27% (multiparous). Rates of paediatric involvement varied from between 37 and 60% (nulliparous) and
from between 26 and 43% (multiparous). For instrumental vaginal births, rates varied from between 16 and
19% (nulliparous) and from between 3 and 4% (multiparous). For intrapartum caesarean section, the variation
was 13–15% and 5–6%, respectively. A positive correlation was found between intervention rates in midwife-
led and obstetrician-led care at the onset of labour within the same region. Adverse neonatal and maternal
outcomes were not lower in regions with higher intervention rates. Higher augmentation of labour rates
correlated with higher rates of severe postpartum haemorrhage.
Conclusions: Most variation was found for type of pain medication and paediatric involvement, and least
for instrumental vaginal births and intrapartum caesarean sections. Care providers and policy makers should critically
audit remarkable variations, since these may be unwarranted. Limited variation for some interventions may indicate
consensus for their use. Further research should focus on variations in evidence-based interventions and
indications for the use of interventions in childbirth.
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Background
The rates of interventions in childbirth vary worldwide
[1–4] and have fluctuated over the years [1, 4–7]. Induc-
tion of labour and caesarean section (CS) rates have
shown a steady increase since the 1970s [1, 4, 6, 8, 9],
which raised concerns [10]. Interventions in childbirth
are important in order to prevent neonatal and maternal
morbidity and mortality. However, use without a medical
indication may cause avoidable harm [2, 11–14]. The
World Health Organization (WHO) recommends lim-
ited use of interventions during childbirth [15]. Induc-
tion and augmentation of labour should only be
performed on medical indication [16, 17]. However,
there are concerns about poor adherence to this recom-
mendation in a significant number of women with un-
complicated pregnancies [16–19]. Epidural analgesia is
the most effective method for pain medication during
labour [20], but is associated with a higher risk of instru-
mental birth, oxytocin use, maternal fever, urinary reten-
tion and complications, such as post-dural puncture
headache [20, 21]. The decision for pain medication is
ultimately based on women’s choice. There is some evi-
dence that continuous support of labour might reduce
the need for pain medication [22]. Furthermore, the
WHO states that CS rates higher than 10 % at popula-
tion level are not associated with reductions in maternal,
neonatal and infant mortality rates [23].
Variations in intervention rates between high-income
countries may be explained by culture and history, dif-
ferences in population characteristics, maternity care
systems, and national guidelines [12, 15, 24–26]. Clinical
guidelines have been used for a long time to harmonise
and rationalise the use of interventions within countries,
and to improve outcomes [27, 28]. Nevertheless, studies
comparing regions within countries like England,
Ireland, Canada and Germany, have found substantial
variations in rates of induction of labour, epidural anal-
gesia, continuous fetal electronic monitoring, episiot-
omy, instrumental birth, and CS [29–33]. Additionally,
Dutch studies have reported variations in rates between
hospitals, of induction and augmentation of labour, ad-
ministration of sedation and analgesics, episiotomy, in-
strumental birth, and CS [34, 35]. Regional variations in
intervention rates, which cannot be explained by mater-
nal characteristics, may indicate over- and underuse
[36]. This is especially true in a relatively small country
without regional differences in the maternity healthcare
system.
The aim of this study was therefore to explore which
regional variations in intervention rates in childbirth
exist, and how these variations are associated both to
each other, and to adverse neonatal and maternal out-
comes. These are explored for single childbirths from
37 weeks of gestation onwards in midwife- or obstetrician-
led care in the Netherlands, and controlled for maternal
characteristics.
Methods
Data collection
For this nationwide study, we used consolidated data of
the years 2010 to 2013 from Perined, the national peri-
natal register that includes data from almost all births in
the Netherlands. Perined aims to improve the quality of
perinatal care through providing data for research and
audits on adverse outcomes. The Perined register in-
cludes data from: primary midwife-led care (the national
perinatal database 1); secondary obstetrician-led care
(the national perinatal database 2); paediatric care (the
national neonatal register); and primary midwifery care
by general practitioners (the national perinatal database
h). The data are routinely recorded by the care providers
and combined into the Perined register via a validated
linkage method [37, 38]. More than 98% of all midwifery
practices and obstetric hospital units record their births
in this combined database [39]. All single childbirths
from 37 weeks’ gestation onwards were included. Exclu-
sion criteria were missing data on: postal code; parity; or
from the national perinatal database 1, covering
midwife-led care, but where the woman was referred to
obstetrician-led care, covered by the national database 2.
In the Netherlands, low-risk women in primary
midwife-led care are cared for by independent midwives
who attend home births, low-risk hospital births, and
births in alongside and free-standing birth centres. The
Dutch Birth Centre Study showed that health outcomes,
experiences, and costs for low-risk women are similar
for planned birth in a birth centre and planned birth in
a hospital, both supervised by a primary care midwife
[40, 41]. When risks for adverse outcomes increase or
complications arise, women are referred to obstetrician-
led care. Interventions in childbirth such as induction
and augmentation of labour, pain medication, instru-
mental birth, and CS, are only available in an
obstetrician-led care setting [42, 43]. Intrapartum inter-
ventions may be used for women in midwife-led care at
the onset of labour after referral to obstetrician-led care.
Therefore, intervention rates are not comparable for
women who are in midwife-led care and women who
are in obstetrician-led care at the onset of labour.
The VU University Medical Center confirmed that eth-
ical approval was not required for this study according to
the Dutch legislation (reference WC2016–055; http://www.
ccmo.nl/en/your-research-does-it-fall-under-the-wmo).
Interventions
Births were attributed to one of the twelve Dutch
administrative provinces (further referred to as ‘regions’)
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according to the residential postal code of the mother.
All low-risk women have access to all types of birth set-
tings, but not all types are present in all regions [44].
We adjusted for this by using the residential postal code
of the mother.
The following interventions were examined as the pri-
mary outcomes: induction of labour; augmentation after a
spontaneous onset of labour; intrapartum oxytocin use;
epidural analgesia; other pharmacological pain relief;
instrumental vaginal birth; CS (prelabour, intrapartum);
and involvement of a paediatrician in the first 24 h after
birth. Births from 42 weeks onwards were not excluded,
because they may explain variation in particularly induc-
tion of labour rates, and they may reflect different policies
between regions. Artificial rupture of membranes before a
spontaneous onset of labour was defined as induction of
labour, and administration of oxytocin to stimulate uterine
contractions after spontaneously ruptured membranes as
augmentation. A CS after spontaneously ruptured mem-
branes was defined as intrapartum CS. Intrapartum oxyto-
cin includes the use of oxytocin for induction or for
augmentation of labour, but not oxytocin use in the third
stage of labour. Women with a prelabour CS were
excluded from the analyses on pain medication. Women
with an intrapartum CS and an epidural, are classified as
epidural analgesia for labour pain, since epidural analgesia
is generally not used for caesarean sections without prior
epidural analgesia for labour pain. In Perined ‘other
pharmacological pain relief ’ is specified as: sedatives; non-
opioid analgesics; and opioid analgesics without further
details. The most common opioid analgesics are pethidine
injections, sometimes combined with a sedative such as
promethazine, and patient-controlled remifentanil [45]. In
some births, epidural analgesia and other pharmacological
methods for pain medication were both used, and there-
fore, the percentages could not be added up [45].
Neonatal and maternal outcomes
The secondary neonatal and maternal outcomes were:
antepartum and intrapartum stillbirth; neonatal mortal-
ity; Apgar score below 7 at 5 min; third or fourth degree
perineal tear among vaginal births; and postpartum
haemorrhage (PPH) of 1000 ml or more. Antepartum
stillbirths with births beyond 37 weeks were included,
since this may influence intervention rates. Neonatal
mortality was defined as neonatal death up to 7 days.
Antepartum and intrapartum stillbirths were excluded
from the analyses on Apgar score. Women who gave
birth by CS were excluded from the analyses on third or
fourth degree perineal tear.
Maternal and neonatal characteristics
The following maternal and neonatal characteristics
were included as independent variables or potential
confounders [29, 30, 32, 46–49]: parity (nulliparous,
multiparous); care setting at the onset of labour (mid-
wife-led, obstetrician-led), maternal age (< 20, 20–24,
25–29, 30–34, 35–39, ≥40 years); ethnic background
(Dutch, non-Dutch); degree of urbanisation (urban,
intermediate, rural); socioeconomic status (high,
medium, low); gestational age (37 + 0–37 + 6, 38 + 0–40
+ 6, 41 + 0–41 + 6, ≥42 weeks); and birth weight (< 2.3rd,
<10th, >90th, > 97.7th percentile). Ethnic background
was reported by the care provider and was defined as
Dutch or non-Dutch, because of inconsistencies in
recording non-Dutch subgroups. The degree of urbanisation
was based on the four digits of the residential postal code of
the mother. For 2500 or more addresses/km2, the degree of
urbanisation was categorized as urban, and for less than 500
addresses/km2 as rural. Socioeconomic status [SES] was
based on a proxy measure indicated by the Netherlands
Institute for Social Research (SCP), which includes
education, employment, and level of income of the
residential postal code area (Statistics Netherlands; https://
bronnen.zorggegevens.nl/Bron?naam=Sociaal-Economische-
Status-per-postcodegebied). SES was classified as high,
medium and low, based on the 25 and 75 percentile
cut-off points.
Data analysis
The baseline characteristics were described in percent-
ages per region. The variation in interventions was
analysed overall, and in subgroups according to the care
setting. Stratification by parity was applied for the crude
rates. Univariable analyses were performed to gain
insight in the variations of intervention rates and child-
birth outcomes in the twelve regions. All interventions
and childbirth outcomes mentioned above were included
in the univariable analyses. The percentages of missing
data were low, namely from between 0.0 to 2.5% for
baseline characteristics, from between 0.0 to 0.8% for
interventions, from between 0.0 to 0.1% for neonatal
outcomes, and from between 1.4 to 2.7% for maternal
outcomes. Therefore, cases with missing data were
excluded.
Multivariable logistic regression analyses were con-
ducted for all births and stratified by the care setting,
with adjustments for: parity; maternal age; ethnic back-
ground; socioeconomic position; and the degree of
urbanisation. The results of the multivariable analyses
were illustrated in figures with maps and boxplots with
adjusted odds ratios (ORs) and 99% confidence intervals
(CIs). The weighted overall intervention rate was taken
as the reference. This weighted rate was the overall
intervention rate, with the intervention rate of the
region weighted for the number of women in each
region. A confidence interval of 99% was chosen to
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limits chance findings due to multiple testing in a large
dataset. Outcome variables were dichotomised and
dummy variables were created to account for potential
confounders in the multivariable logistic regression ana-
lyses. An important topic of this study, was to explore
whether the variation of one intervention was associated
with the variation of another intervention. Instead of ex-
ploring associations with eyeballing only, we quantified
these associations by calculating Spearman’s rank correl-
ation coefficients. These were calculated to demonstrate
the associations of regional adjusted ORs between inter-
ventions in different care settings, and between interven-
tions and childbirth outcomes. Correlation coefficients
were calculated for the adjusted ORs of the regions, but
only for outcomes that varied significantly between the re-
gions. Since the sample size for all calculated correlations
was the same, namely 12 regions, all correlations with ρ ≥
0.57 or ≤ − 0.57 corresponded with a p-value of 0.05. Al-
though the limits for clinically significant correlations are
arbitrary, we considered a correlation of ρ ≥ 0.60
or ≤ − 0.60 as strong [50], and only these correlations were
discussed in the text and indicated in bold in the tables.
Statistical analyses were performed using SPSS Statis-
tics 22 (SPSS Inc., Chicago, IL, USA).
First, overall results and remarkable associations be-
tween subgroups of women or between interventions
were described. Second, results for each intervention
were described, starting with those that showed most
variation.
Results
Baseline characteristics
Figure 1 shows the number of births eligible for inclusion
in this study and Table 1 describes the maternal and neo-
natal characteristics. Of the 276,701 births in nulliparous
women, 153,091 were in midwife-led care at the onset of
labour, 121,612 in obstetrician-led care, and for the
remainder, the care setting was unknown. For births in
multiparous women, these numbers were 174,918 and
161,286 respectively. In the regions, the proportion of
mothers younger than 20 years of age ranged from be-
tween 0.8 to 2.2%, and of 40 years or older from between
2.4 to 4.5%. The lowest proportion of mothers with a non-
Dutch ethnicity was 9.3% and the highest 34.6%. In three
Women who gave 
birth in 2010-2013
n = 703,942 Women excluded from the study, in order of 
exclusion:
- multiple gestation (n=23,376) or 
missing information (n=613)
- birthbefore 37 weeks gestation
(only singletons: n=47,700)
-missing postcode (n=5,888), parity (n=26)
or national perinatal database 1 in case of 
referral to obstetrician-led care (n=11,609)
n = 89,212Women who gave birth to a 
single child from 37 weeks 
gestation onwards
n = 614,730
Multiparous women
n = 338,029
Nulliparous women
n = 276,701
In midwife-led 
care at onset 
of labour
n = 153,091
In obstetrician-
led care at 
onset of labour
n = 121,612
In midwife-led 
care at onset 
of labour
n = 174,918
In obstetrician-
led care at 
onset of labour
n = 161,286
Unknown
n = 1,998
Unknown
n= 1,825
Fig. 1 Study population
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regions, there were no urban areas, whereas in all regions
there were mothers living in rural areas, with a range of
between 11.1 and 48.5%. Proportions of mothers with a low
socioeconomic status varied from between 24.1 to 59.2%.
Regions with the lowest number of births after
42 weeks (varying from between 0.8 to 2.5%), had
higher numbers of births at 37–38 weeks (varying
from between 5.8 to 9.2%), and vice versa. We found
a similar pattern for birth weight below the 2.3rd,
10th or above the 90th or 97.7th percentile, with
rates varying from between 1.4 to 2.1% for birth
weight below the 2.3rd percentile, and from between
2.3 to 3.5% for birth weight above the 97.7th.
Results on the national level
The greatest variation was found for the type of pain medi-
cation and whether a paediatrician was involved within
24 h after birth, followed by variation in augmentation after
a spontaneous onset of labour. Less variation was found for
induction of labour and prelabour CSs, and least for instru-
mental vaginal births and intrapartum CSs (Figs. 2, 3, 4, 5, 6
and 7). Similar variation in intervention rates was found for
births in midwife-led care compared to those in
obstetrician-led care at the onset of labour in the same
region (Additional file 1: Table S5). The adverse neonatal
and maternal outcomes were not lower in regions with
higher intervention rates (Additional file 1: Table S8).
Table 1 Maternal and neonatal characteristics of women by region
GR FR DR OV FL GD UT NH ZH ZL NB LB
Total n 19,441 22,568 15,875 42,869 17,461 71,286 52,893 105,948 139,573 11,327 84,187 31,302
Parity, %
Nulliparous 45.8 42.4 42.7 42.1 41.4 43.4 44.7 46.8 45.7 42.8 45.8 47.2
Multiparous 54.2 57.6 57.3 57.9 58.6 56.6 55.3 53.2 54.3 57.2 54.2 52.8
Maternal age, %
< 20 years 1.9 1.5 1.6 1.2 2.2 1.2 0.8 1.0 1.5 1.6 1.0 1.6
20–24 years 12.4 11.5 11.6 10.0 13.9 10.0 7.5 8.4 11.7 15.2 8.7 10.6
25–29 years 31.2 34.8 35.4 33.4 33.9 31.6 26.7 26.2 30.3 33.9 31.5 32.2
30–34 years 35.4 35.1 34.2 38.0 32.3 37.5 40.6 38.2 35.6 33.1 39.8 37.8
35–39 years 16.1 14.5 14.7 14.9 14.6 16.6 20.9 21.6 17.4 13.6 16.5 15.2
≥40 years 2.9 2.7 2.5 2.4 3.0 3.1 3.6 4.5 3.5 2.7 2.5 2.7
Ethnic background, %
Dutch 85.7 90.7 89.9 86.2 65.4 85.6 77.5 67.1 65.4 87.2 80.1 82.7
Non-Dutch 14.3 9.3 10.1 13.8 34.6 14.4 22.5 32.9 34.6 12.8 19.9 17.3
Urbanisation, %
Urban 18.0 4.6 0.0 2.9 0.0 3.8 23.0 39.8 41.7 0.0 9.0 2.5
Intermediate 49.2 47.0 53.6 71.3 72.5 71.4 59.6 49.1 45.0 53.3 70.0 69.7
Rural 32.9 48.5 46.4 25.9 27.5 24.8 17.4 11.1 13.3 46.7 21.0 27.8
Socioeconomic status, %
High (p≥ 75) 9.3 11.8 19.4 16.9 39.2 19.1 35.7 23.5 25.5 7.4 20.0 8.7
Medium (p 25–75) 31.5 34.8 40.5 51.4 36.8 56.0 38.8 39.0 39.1 60.3 55.8 58.4
Low (p ≤ 25) 59.2 53.4 40.0 31.7 24.1 24.9 25.4 37.5 35.4 32.2 24.1 32.9
Gestational age (weeks), %
37 + 0–37 + 6 8.7 8.3 9.2 8.6 8.4 6.7 5.8 6.6 7.6 6.5 7.3 8.8
38 + 0–40 + 6 71.5 71.7 72.5 72.1 73.1 71.6 71.2 72.2 72.8 71.6 72.4 73.9
41 + 0–41 + 6 17.9 18.1 16.9 17.4 16.9 19.3 20.7 19.0 18.3 19.4 18.5 16.5
≥42 1.8 1.9 1.4 1.8 1.6 2.3 2.3 2.2 1.4 2.5 1.8 0.8
Birth weight, %
< 2,3rd percentile 1.7 1.4 1.4 1.5 1.8 1.6 1.7 1.8 1.9 2.0 2.0 2.1
<10th percentile 8.0 6.8 7.3 7.4 9.5 7.8 7.9 8.4 8.9 8.8 9.3 9.7
>90th percentile 11.3 12.9 11.9 11.0 9.8 11.2 10.6 10.3 9.7 10.0 9.0 9.0
> 97,7th percentile 3.0 3.5 3.4 2.9 2.4 3.0 2.7 2.7 2.5 2.4 2.3 2.4
Percentage of missing data: 0.0% for maternal age, 0.4% for ethnic background, 1.1% for urbanisation, 2.5% for socioeconomic status, 0.2% for birth weight
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Adjusted OR for epidural analgesia with 99% confidence interval
Adjusted OR for other pharmacological pain relief with 99% confidence interval
The reference category (OR of 1.0) is the weighted overall rate of the country
(rho) is the coefficient between the two point markers in the figure (epidural analgesia
and other pharmacological pain relief), which corresponds with the correlation coefficient
described in table 6.
a
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Fig. 2 a: Regional variation of epidural analgesia and other pharmacological pain relief for women in midwife-led care. b: Regional variation of
epidural analgesia and other pharmacological pain relief for women in obstetrician-led care
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Regional variations
Table 2 describes the intervention rates by region in sub-
groups stratified by parity, and Additional file 2: Table S4
the crude and adjusted ORs with confidence intervals, on
which Figs. 2, 3, 4, 5, 6 and 7 are based. Most variation
was found for the type of pain medication during labour
(Fig. 2a and b), with epidural analgesia rates varying from
between 12.3 to 37.5% in nulliparous and from between
4.6 to 13.8% in multiparous women, and rates of other
pharmacological pain relief varying from between 14.8 to
43.0% in nulliparous and from between 9.8 to 26.8% in
multiparous women without prelabour CS (Table 2). The
variation of pain medication was similar for women in
midwife-led compared to those in obstetrician-led care
within the same region, with ρ = 0.97 (Additional file 1:
Table S5), but rates were lower for women in midwife-led
care. Generally, lower rates of other pharmacological pain
relief were found in regions with higher rates of epidural
analgesia, and vice versa. The correlation coefficient was
ρ = − 0.61 for women in midwife-led care and ρ = − 0.68 in
obstetrician-led care (Additional file 1: Table S6). There
were no significant correlations between the use of pain
medication and augmentation of labour, intrapartum oxy-
tocin use, instrumental vaginal birth, intrapartum CS, or
spontaneous vaginal birth (Additional file 1: Table S7). As
can be seen from Fig. 3, considerable variation was found
for the involvement of a paediatrician in the first 24 h after
birth, with rates varying from between 36.9 to 60.3% for
nulliparous and from between 25.6 to 42.7% for multipar-
ous women (Table 2).
Figure 4 shows maps with variations of spontaneous
birth rates, CS rates, and rates of intrapartum oxytocin
between regions. Rates of intrapartum oxytocin, used for
induction or augmentation of labour, were found of
between 55.1 and 66.5% for nulliparous and of between
39.7 and 51.7% for multiparous women (Table 2), and
varied significantly across regions (Fig. 4c). Rates of aug-
mentation after a spontaneous onset of labour varied
across regions from between 33.5 to 48.4% for nullipar-
ous and from between 12.4 to 22.6% for multiparous
women (Table 2). Instrumental vaginal birth rates were
lower (ρ = − 0.61) and spontaneous vaginal birth rates
0,4
0,5
0,6
0,7
0,8
0,9
1
1,1
1,2
1,3
1,4
1,5
1,6
1,7
GR FR DR OV FL GD UT NH ZH ZL NB LB
= 0.67
Adjusted OR for involvement of a paediatrician <24 hrs among women in midwife-
led care with 99% confidence interval
Adjusted OR for involvement of a paediatrician <24 hrs among women in 
obstetrician-led care with 99% confidence interval
The reference category (OR of 1.0) is the weighted overall rate of the country.
(rho) is the coefficient between the two point markers in the figure (paediatric 
involvement for women in midwife-led versus obstetrician-led care), which corresponds
with the correlation coefficient described in table 5.
Fig. 3 Regional variation of paediatric involvement for women in midwife-led care and obstetrician-led care
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were higher (ρ = 0.66; Additional file 1: Table S7) in re-
gions where rates of augmentation of labour were
higher. Variations in augmentation of labour are shown
in Fig. 5.
Less variation was found for induction of labour,
instrumental vaginal birth, and prelabour and intra-
partum CS. Rates of prelabour CS were found of be-
tween 3.6 and 5.8% for all nulliparous and of between
5.8 and 9.8% for all multiparous women, and induc-
tion of labour rates of between 18.0 and 26.2% for all
nulliparous and of between 16.6 and 25.4% for all
multiparous women (Table 2). Figure 6 illustrates the
ORs of prelabour CS and induction of labour. Regions
with higher rates of prelabour CS had higher rates of
intrapartum CS as well (ρ = 0.67), and lower rates of
spontaneous vaginal births (ρ = − 0.62; Additional file 1:
Table S7).
Compared to the other interventions, least variation
was found for intrapartum CS and instrumental vaginal
birth for women without prelabour CS (Fig. 7a and b).
Intrapartum CS rates varied from between 12.7 to 15.4%
(nulliparous women) and from between 5.3 to 6.4%
(multiparous women), and instrumental birth rates
varied from between 16.2 to 19.4% (nulliparous
women) and from between 3.1 to 4.2% (multiparous
women) (Table 2). For midwife-led care, regions with
higher intrapartum CS rates had higher instrumental
birth rates as well (ρ = 0.60), but this correlation was
not significant in obstetrician-led care at the onset
labour (ρ = 0.45; Additional file 1: Table S6). For all
nulliparous women, a variation of spontaneous vaginal
birth rates was found of between 62.4 and 67.4%, and
for multiparous women, of between 81.7 and 86.1%
(Table 2).
Neonatal and maternal outcomes
The results of the multivariable analyses for the child-
birth outcomes are described in Table 3. The overall
incidence of antepartum and intrapartum stillbirth
was 0.12% and of neonatal mortality up to 7 days 0.08%,
but the adjusted ORs did not vary significantly
GR=Groningen; 
FR=Friesland; 
DR=Drenthe; 
OV=Overijssel; 
FL=Flevoland; 
GD=Gelderland; 
UT=Utrecht; 
NH=Noord-Holland; 
ZH=Zuid-Holland; 
ZL=Zeeland; 
NB=Noord-Brabant; 
LB=Limburg.
Fig. 4 Significant differences in adjusted* OR between regions in incidences of: a. spontaneous births. b. caesarean sections. c. intrapartum
oxytocin use. (* Adjusted for parity, maternal age, ethnic background, socioeconomic status and urbanisation)
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between regions (Table 3; not shown in figures).
Correlation coefficients were therefore not calculated
for these outcomes. The incidence of Apgar score
below 7 at 5 min varied significantly across regions
from between 0.7 to 1.5%. For third and fourth
degree perineal tear, incidences varied from between
1.8 to 3.2% and for PPH from between 3.7 to 6.9%.
The only intervention and adverse outcome that
were significantly correlated, were augmentation of
labour after a spontaneous onset of labour and PPH
(ρ = 0.87; Additional file 1: Table S8).
Discussion
In this nationwide study, most interregional variation
was found for the different types of pain medication
(epidural analgesia or other pharmacological pain relief ),
and for the involvement of a paediatrician in the first
24 h after birth. Less variation was found for prelabour
CS, augmentation and induction of labour, and least for
instrumental vaginal birth and intrapartum CS rates.
Regions with higher rates of one intervention did not
have higher rates of all other interventions. Interventions
that were correlated, were epidural analgesia and other
pharmacological pain relief (negatively), augmentation of
labour and instrumental vaginal birth (negatively), intra-
partum CS and prelabour CS (positively), and for
women in midwife-led care at the onset of labour, intra-
partum CS and instrumental vaginal birth (positively).
Regional variation was similar for women in midwife-led
compared to those in obstetrician-led care within the
same region. PPH occurred more often in regions where
rates of augmentation of labour were higher. Antepartum
0,5
0,6
0,7
0,8
0,9
1
1,1
1,2
1,3
1,4
1,5
1,6
1,7
1,8
GR FR DR OV FL GD UT NH ZH ZL NB LB
= 0.76
Adjusted OR for augmentation of labour women in midwife-led care with 99% 
confidence interval
Adjusted OR for augmentation of labour among women in obstetrician-led care
with 99% confidence interval
The reference category (OR of 1.0) is the weighted overall rate of the country.
(rho) is the coefficient between the two point markers in the figure (augmentation of 
labour for women in midwife-led versus obstetrician-led care), which corresponds with the
correlation coefficient described in table 5.
Fig. 5 Regional variation of augmentation of labour after spontaneous onset for women in midwife-led care and obstetrician-led care
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and neonatal mortality rates did not vary significantly.
Regions with higher intervention rates did not have lower
rates of adverse neonatal and maternal outcomes, or vice
versa.
Limitations and strengths
This study is based on routinely collected data. Reporting
bias is an issue in any register dataset, particularly for sub-
jective outcomes, such as Apgar score and blood loss. Pitfalls
in the use of these register-based data are described in a re-
cent article of De Jonge et al. [44]. Misclassification is ex-
pected to be similar across regions and it is unlikely that it
accounts for any of the variations. Another limitation is the
absence or incompleteness of some variables in the dataset,
such as maternal body mass index, congenital disorders, and
obstetric history of low birth weight or previous CS.
However, it is unlikely that this explains all variations ob-
served, because adjustments for maternal characteristics did
not lead to considerable changes in regional variation. Be-
sides, it does not explain the large variation in pain medica-
tion and involvement of a paediatrician. On the other hand,
regional variations in subgroups of different ethnic back-
grounds could explain some of the variations. Secondly, re-
gions with higher rates of referrals from midwife-led to
obstetrician-led care, may have more low- or medium-risk
women in obstetrician-led care, which might be reflected by
lower intervention rates in obstetrician-led care, and higher
rates in midwife-led care. However, our results showed
strong positive correlations between intervention rates in
midwife-led and obstetrician-led care within the same re-
gion. Last, by calculating correlation coefficients between re-
gional adjusted ORs, it was not possible to account for the
0,5
0,6
0,7
0,8
0,9
1
1,1
1,2
1,3
1,4
1,5
1,6
1,7
1,8
GR FR DR OV FL GD UT NH ZH ZL NB LB
= 0.19
Adjusted OR for prelabour CS with 99% confidence interval
Adjusted OR for induction of labour with 99% confidence interval
The reference category (OR of 1.0) is the weighted overall rate of the country.
(rho) is the coefficient between the two point markers in the figure (prelabour CS and 
induction of labour), which corresponds with the correlation coefficient described in table 7.
Fig. 6 Regional variation of prelabour CS and induction of labour for all women
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= 0.60
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a
b
Fig. 7 a: Regional variation of intrapartum CS and instrumental birth for women in midwife-led care. b: Regional variation of intrapartum CS and
instrumental birth for women in obstetrician-led care
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Table 2 Childbirth intervention rates by region total, and in subgroups by setting, stratified by parity (percentages)
Nulliparous women, total and by care setting at the onset of labour (abbreviated as ‘midwife’ or ‘obstetrician’)
Total GR FR DR OV FL GD UT NH ZH ZL NB LB
Total n
All women 276,701 8901 9564 6785 18,051 7233 30,961 23,662 49,582 63,785 4853 38,544 14,780
Midwife 153,091 4827 5701 3550 10,292 3979 18,559 14,293 29,280 32,817 2695 20,2019 6879
Obstetrician 121,612 4045 3831 3217 7648 3230 12,247 9266 19,663 30,283 2140 18,198 7844
Induction of labour, %
All women 21.2 24.8 20.7 26.2 23.3 20.8 18.6 18.0 19.1 23.0 22.4 21.4 24.4
Obstetrician 48.2 54.6 52.2 55.1 54.3 46.9 47.0 46.1 47.6 48.0 51.2 45.5 46.3
Augmentation after spontaneous onset of labour, %
All women 42.9 40.7 38.0 41.5 36.2 48.4 44.3 45.9 43.7 42.1 33.5 45.6 42.2
Midwife 39.1 37.9 34.8 37.5 32.7 43.3 41.2 43.4 40.3 37.1 29.5 41.8 37.6
Obstetrician 54.5 49.9 51.5 53.9 48.9 62.6 55.1 54.7 55.6 54.9 47.1 56.0 52.0
Intrapartum oxytocin use, %
All women 62.2 62.4 61.7 63.3 59.0 66.5 64.3 65.6 63.4 62.4 55.1 59.9 58.0
Obstetrician 61.6 64.6 64.4 67.5 60.9 69.5 63.2 63.7 62.1 60.9 56.5 58.7 58.4
Epidural, %
All women without prelabour CS 27.4 25.4 20.1 12.3 27.7 13.7 27.6 31.0 22.3 27.3 19.1 37.5 36.4
Midwife 19.8 19.5 14.2 7.9 19.8 8.7 20.9 24.4 16.0 17.9 13.0 28.8 26.2
Obstetrician without prelabour CS 38.1 33.1 30.0 17.7 39.3 20.1 38.7 42.4 32.6 38.5 27.7 48.4 46.3
Other pharmacological pain relief, %
All women without prelabour CS 21.6 20.1 20.6 38.2 16.2 43.0 17.6 14.8 24.6 22.3 25.6 17.2 27.9
Midwife 17.7 14.7 16.5 30.0 13.0 35.4 14.8 13.1 21.2 17.6 19.0 14.8 20.9
Obstetrician without prelabour CS 27.1 27.1 27.6 48.0 20.8 53.1 22.0 17.7 29.8 28.0 34.8 20.1 34.7
Spontaneous vaginal birth, %
All women 65.2 62.4 64.0 66.0 64.1 64.6 67.4 66.8 64.6 64.1 66.2 66.2 64.9
Midwife 74.3 72.0 72.7 74.5 73.1 71.8 75.6 75.2 73.2 74.3 75.9 75.7 75.8
Obstetrician 53.6 51.2 51.2 56.6 51.9 55.9 54.9 53.9 51.8 53.0 53.9 55.4 55.4
Instrumental vaginal birth, %
All women (without prelabour CS) 17.9 19.3 17.8 17.5 19.4 18.5 17.1 17.2 18.3 19.1 17.0 16.2 16.6
Midwife 17.0 18.5 17.1 17.7 18.3 18.5 16.4 16.3 17.5 17.3 15.6 15.9 15.9
Obstetrician (without prelabour CS) 19.2 20.2 18.9 17.4 21.1 18.5 18.2 18.7 19.7 21.1 18.9 16.5 17.3
Caesarean Section, %
All women 17.8 19.3 19.0 17.2 17.4 17.6 16.3 16.7 17.9 17.7 17.6 18.5 19.4
Prelabour CS, %
All women 4.5 4.6 4.7 4.1 4.4 3.6 4.1 4.2 4.3 4.4 4.6 5.2 5.8
Obstetrician 10.2 10.0 11.5 8.6 10.2 7.9 10.2 10.6 10.7 9.2 10.4 11.1 10.8
Intrapartum CS, %
All women (without prelabour CS) 13.9 15.4 15.1 13.7 13.6 14.6 12.7 13.1 14.2 13.9 13.7 14.0 14.4
Midwife 8.6 9.6 10.2 7.7 8.5 9.7 7.9 8.5 9.3 8.4 8.5 8.3 8.2
Obstetrician (without prelabour CS) 21.2 23.0 23.3 20.9 21.2 21.0 20.7 21.1 22.3 20.5 21.0 21.2 20.6
Involvement paediatrician < 24 h, %
All women 50.4 59.6 49.9 51.1 47.7 48.3 55.9 60.0 36.9 50.8 46.9 53.0 60.3
Midwife 38.1 45.6 37.9 37.2 34.8 38.1 43.4 49.0 26.9 36.5 32.5 42.5 47.0
Obstetrician 65.8 76.3 67.6 66.5 64.8 60.8 74.7 76.9 51.6 66.4 65.6 64.5 71.9
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Table 2 Childbirth intervention rates by region total, and in subgroups by setting, stratified by parity (percentages) (Continued)
Nulliparous women, total and by care setting at the onset of labour (abbreviated as ‘midwife’ or ‘obstetrician’)
Total GR FR DR OV FL GD UT NH ZH ZL NB LB
Multiparous women, total and by care setting at the onset of labour (abbreviated as ‘midwife’ or ‘obstetrician’)
Total GR FR DR OV FL GD UT NH ZH ZL NB LB
Total n
All women 338,029 10,540 13,004 9090 24,818 10,228 40,325 29,231 56,366 75,788 6474 45,643 16,522
Midwife 174,918 5186 7200 4334 13,630 4963 22,842 16,308 30,470 37,206 3373 21,821 7585
Obstetrician 161,286 5331 5765 4735 11,070 5246 17,324 12,812 25,414 37,940 3082 23,705 8862
Induction of labour, %
All women 19.7 23.8 19.0 25.4 20.2 22.2 17.7 16.6 18.0 21.1 20.6 20.1 21.2
Obstetrician 41.1 47.0 43.0 48.8 44.8 43.3 41.1 37.6 39.4 41.7 43.3 38.8 39.7
Augmentation after spontaneous onset of labour, %
All women 17.3 14.5 14.8 18.0 14.0 22.6 17.2 16.1 17.9 18.4 12.4 18.8 16.6
Midwife 11.2 8.8 9.5 12.0 8.6 14.2 11.3 11.5 12.1 11.6 7.1 11.7 10.1
Obstetrician 33.2 29.3 32.5 33.2 30.9 41.3 34.3 29.4 34.6 33.9 27.2 33.8 30.2
Intrapartum oxytocin use, %
All women 44.7 47.0 47.6 51.7 44.5 51.7 46.3 43.4 45.4 45.6 41.4 40.1 39.7
Obstetrician 45.8 50.3 50.0 54.2 46.6 54.3 47.8 43.9 45.8 45.9 42.9 41.0 41.5
Epidural, %
All women without prelabour CS 9.6 8.9 7.0 4.6 8.4 4.9 9.3 10.4 8.0 9.7 7.6 13.8 13.8
Midwife 3.0 2.7 2.0 0.8 2.2 1.6 3.0 4.2 2.6 2.6 2.3 4.8 4.3
Obstetrician without prelabour CS 18.1 16.0 14.5 8.6 17.5 8.6 18.7 19.9 15.8 18.1 14.7 23.8 23.6
Other pharmacological pain relief, %
All women without prelabour CS 14.5 12.4 14.3 22.9 11.7 26.8 11.2 9.8 14.5 15.1 14.4 15.0 19.9
Midwife 6.6 5.0 5.6 9.5 5.2 12.6 5.3 5.1 7.2 6.5 4.7 7.9 8.4
Obstetrician without prelabour CS 24.6 20.8 27.3 37.3 21.3 42.5 20.0 17.0 25.0 25.1 26.8 23.0 31.7
Spontaneous vaginal birth, %
All women 83.7 82.9 82.5 83.8 83.6 84.9 86.1 84.2 82.8 83.4 83.9 83.6 81.7
Midwife 96.9 96.6 96.2 97.3 96.6 96.9 97.2 97.1 96.8 96.8 97.1 96.9 97.1
Obstetrician 69.3 69.7 65.2 71.5 67.5 73.6 71.5 67.9 66.0 70.1 69.4 71.1 68.6
Instrumental vaginal birth, %
All women (without prelabour CS) 3.5 3.7 4.1 3.5 4.2 3.1 3.3 3.1 3.1 3.8 3.7 3.1 3.5
Midwife 1.8 1.7 2.1 1.7 2.2 1.6 1.6 1.7 1.6 1.9 1.8 1.7 1.7
Obstetrician (without prelabour CS) 5.7 6.0 7.0 5.5 7.2 4.8 5.9 5.3 5.4 6.0 6.1 4.6 5.4
Caesarean Section, %
All women 13.2 13.7 13.8 13.0 12.6 12.2 10.8 12.9 14.3 13.2 12.7 13.6 15.2
Prelabour CS, %
All women 7.8 7.9 7.8 7.7 7.7 7.2 5.8 8.0 8.5 7.9 7.7 8.2 9.8
Obstetrician 16.4 15.6 17.6 14.7 17.1 14.0 13.4 18.2 18.8 15.6 16.3 15.9 18.0
Intrapartum CS, %
All women (without prelabour CS) 5.8 6.2 6.4 5.7 5.3 5.4 5.3 5.4 6.3 5.8 5.4 5.9 6.0
Midwife 1.3 1.7 1.6 1.0 1.2 1.5 1.2 1.2 1.5 1.4 1.1 1.4 1.1
Obstetrician (without prelabour CS) 11.6 11.4 13.8 10.7 11.4 9.6 11.5 11.8 13.4 11.0 11.2 10.9 11.0
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confidence intervals of the ORs. Therefore, these calculated
correlations are only a rough indicator of relevant and sig-
nificant correlations between variables. Besides, in case of
minor variation in ORs, a Spearman’s rank correlation coef-
ficient readily becomes insignificant, since it is based on
ranking of the twelve regions. The Spearman’s rank correl-
ation coefficients should be interpreted with caution, also
because of multiple testing.
To our knowledge, this is the first study investigating re-
gional variations of multiple interventions in childbirth in
the Netherlands. A major strength of this study is its inclu-
sion of almost all births in the Netherlands between 2010
and 2013. As stated in a Lancet series on Midwifery, avail-
able data strongly suggest an urgent need for more re-
search to assess the appropriate use of interventions in
childbirth [10]. This study contributes to this need. Be-
cause the results were described separately for women in
midwife- and obstetrician-led care at the onset labour, it
has become clearer in which subgroups variations in inter-
ventions are more prevalent. Another strength of this ex-
plorative study is the comparison of groups of births based
on the mothers’ residential postal codes rather than her
place of birth. Presence of a tertiary academic hospital in a
region has had limited impact on results in this way, since
in all regions both low- and high risk women are repre-
sented, women have access to all types of birth settings,
while not all types are present in all regions, and con-
founders are more equally distributed than between hospi-
tals [44]. However, other confounders, such as distance to
a hospital, may still have influenced the outcomes.
Multilevel analyses were not performed, since the aim
of this study was to explore regional variations that are
not explained by maternal characteristics but may be
explained by variations between care professionals and/
or care settings (midwifery practices, hospitals).
Interpretation and further research
The results from previous studies on regional variations
in perinatal mortality and PPH in the Netherlands were
not completely consistent with our results, probably due
to older data and different samples [49, 51]. It is not
possible to establish causal relationship in our study, for
instance between augmentation of labour and severe
PPH. However, the results are consistent with findings
from previous studies that showed an association
between oxytocin use during labour and severe PPH [52,
53]. Other studies showed greater variations between
regions within a country than our study [29, 31–33, 54,
55]. Although variation in for instance augmentation of
labour appears limited, an additional 10,300 nulliparous
women would receive oxytocin for augmentation each
year if the highest regional rate would become the na-
tional rate, compared to the lowest rate. Even in case of
limited variation in intervention rates, crude numbers
show that variation might nonetheless be unwarranted.
An aim of evidence-based practice is to minimize un-
warranted variation in the use of interventions [56, 57].
However, it is still unknown what would be the best rate
for augmentation of labour and for other interventions.
Regions with higher rates of augmentation of labour had
on one hand higher rates of PPH, but on the other hand
lower instrumental vaginal birth rates. Whether there is
a causal relationship between these variables, needs to
be investigated in further research. Generally, the opti-
mal rate is the lowest rate with comparable neonatal and
maternal outcomes. In our study adverse neonatal and
maternal outcomes were not lower in regions with
higher intervention rates. However, achieving a low
intervention rate should not be an aim in itself [10, 57].
It is not possible to identify the optimal rate of interven-
tions based on this study. An essential element in improv-
ing quality of care, is that care providers critically audit
remarkably high and low rates [10, 58]. This study intends
to contribute to this debate. Following national guidelines
and using the recommendations of the WHO might
help in achieving the optimal use of interventions
[15–17, 23, 58].
On the other hand, differences in regional guidelines
and in adherence to national guidelines may explain a part
of the large variation in type of pain medication and in-
volvement of a paediatrician. Use of epidural analgesia for
women with a single fetus in cephalic position after
37 weeks’ gestation, has almost tripled between 2000 and
2009 in the Netherlands (from 7.7 to 21.9%) [59]. In 2008,
a multidisciplinary guideline on pain medication was pub-
lished, in which adequate pain relief upon request for all
Table 2 Childbirth intervention rates by region total, and in subgroups by setting, stratified by parity (percentages) (Continued)
Nulliparous women, total and by care setting at the onset of labour (abbreviated as ‘midwife’ or ‘obstetrician’)
Total GR FR DR OV FL GD UT NH ZH ZL NB LB
Involvement paediatrician < 24 h, %
All women 35.6 41.1 34.5 36.3 33.9 34.0 37.8 41.9 25.6 37.0 36.0 37.0 42.7
Midwife 14.6 16.6 14.2 13.7 13.1 14.8 16.4 19.6 9.2 14.4 11.7 16.8 19.2
Obstetrician 58.2 65.0 59.9 57.0 59.3 52.0 66.1 70.2 45.2 59.1 62.7 55.5 62.7
Percentage of missing data: 0.6 for midwife- or obstetrician-led care, 0.7% for spontaneous vaginal birth, 0.7% for instrumental birth, 0.7% for caesarean section,
0.8% for induction of labour, 0.6% for augmentation of labour, 0.0% for oxytocin use, 0.4% for epidural and other pharmacological pain relief, 0.3% for involvement
paediatrician < 24 h
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women during labour was advised, with epidural analgesia
as the most effective method for pain relief. Two random-
ized controlled trials showed that women were more satis-
fied with epidural analgesia compared to patient-
controlled remifentanil [60, 61], but access to pain medi-
cation should not be at the expense of continuous sup-
port, which can reduce the need for pain medication [22].
The large variation in rates of pain medication sug-
gests different degrees of implementation of evidence
and national guidelines, leading to disparity in acces-
sibility to pain medication. Furthermore, the absence
of a national guideline on when a paediatrician needs
to be involved after birth and differences in accessi-
bility may explain a part of the large variation in the
Table 3 Neonatal and maternal outcomes by region (percentages, crude and adjusteda ORs, compared to weighted mean, with 99% CIs
Total GR FR DR OV FL GD UT NH ZH ZL NB LB
614,661 19,441 22,568 15,875 42,860 17,461 71,284 52,886 105,944 139,567 11,327 84,147 31,301
Antepartum and
intrapartum stillbirth,
n (%)
717
(0.12)
23
(0.12)
32
2(0.14)
17
(0.11)
42
(0.10)
27
(0.15)
97
(0.14)
62
(0.12)
126
(0.12)
159
(0.11)
11
(0.10)
88
(0.10)
33
(0.11)
Crude OR [99% CI] 1.02
[0.61–
1.69]
1.22
[0.79–
1.88]
0.92
[0.51–
1.65]
0.84
[0.57–
1.24]
1.33
[0.83–
2.13]
1.17
[0.89–
1.53]
1.01
[0.73–
1.39]
1.02
[0.80–
1.31]
0.98
[0.78–
1.23]
0.83
[0.41–
1.71]
0.90
[0.68–
1.19]
0.90
[0.59–
1.39]
aORa [99% CI] 1.04
[0.62–
1.73]
1.26
[0.81–
1.97]
0.93
[0.51–
1.71]
0.90
[0.61–
1.33]
1.41
[0.86–
2.32]
1.13
[0.85–
1.50]
1.07
[0.76–
1.50]
0.97
[0.74–
1.27]
0.97
[0.75–
1.25]
0.75
[0.35–
1.61]
0.85
[0.63–
1.14]
0.89
[0.58–
1.37]
Neonatal mortality
up to 7 days, n (%)
471
(0.08)
14
(0.07)
13
(0.06)
12
(0.08)
29
(0.07)
14
(0.08)
72
(0.10)
42
(0.08)
85
(0.08)
98
(0.07)
12
(0.11)
52
(0.06)
28
(0.09)
Crude OR [99% CI] 0.93
[0.49–
1.78]
0.75
[0.38–
1.46]
0.98
[0.49–
1.97]
0.88
[0.55–
1.39]
1.04
[0.54–
1.99]
1.31
[0.95–
1.80]
1.03
[0.69–
1.53]
1.04
[0.77–
1.40]
0.91
[0.68–
1.21]
1.37
[0.68–
2.76]
0.80
[0.56–
1.15]
1.16
[0.72–
1.86]
aORa [99% CI] 0.93
[0.48–
1.79]
0.76
[0.39–
1.51]
1.06
[0.52–
2.14]
0.83
[0.51–
1.36]
1.04
[0.52–
2.11]
1.34
[0.97–
1.86]
1.02
[0.67–
1.57]
1.01
[0.73–
1.40]
0.92
[0.67–
1.27]
1.38
[0.68–
2.79]
0.80
[0.56–
1.16]
1.08
[0.67–
1.76]
Apgar score below
7 at 5 minutesb, n (%)
6410
(1.00)
291
(1.5)
280
(1.2)
132
(0.8)
354
(0.8)
163
(0.9)
715
(1.0)
460
(0.9)
1136
(1.1)
1735
(1.2)
83
(0.7)
777
(0.9)
284
(0.9)
Crude OR [99% CI] 1.53
[1.32–
1.77]
1.26
[1.09–
1.46]
0.84
[0.68–
1.04]
0.84
[0.73–
0.96]
0.95
[0.78–
1.14]
1.02
[0.92–
1.12]
0.88
[0.78–
0.99]
1.09
[1.00–
1.18]
1.26
[1.17–
1.36]
0.74
[0.57–
0.96]
0.94
[0.85–
1.03]
0.92
[0.79–
1.07]
aORa [99% CI] 1.47
[1.26–
1.71]
1.28
[1.10–
1.49]
0.90
[0.73–
1.12]
0.85
[0.74–
0.98]
0.96
[0.78–
1.18]
1.05
[0.95–
1.17]
0.88
[0.78–
0.997]
0.99
[0.90–
1.08]
1.18
[1.09–
1.28]
0.78
[0.60–
1.02]
0.94
[0.85–
1.03]
0.92
[0.79–
1.07]
3rd and 4th degree
perineal tear for
vaginal births, %
14,065
(2.76)
432
(2.68)
528
(2.84)
423
(3.15)
1061
(2.95)
369
(2.49)
1638
(2.68)
1369
(3.07)
2741
(3.13)
2725
(2.38)
173
(1.83)
1919
(2.79)
687
(2.73)
Crude OR [99% CI] 0.99
[0.88–
1.12]
1.05
[0.94–
1.17]
1.17
[1.04–
1.32]
1.10
[1.01–
1.19]
0.92
[0.81–
1.04]
0.99
[0.93–
1.06]
1.14
[1.06–
1.23]
1.16
[1.10–
1.23]
0.88
[0.83–
0.93]
0.67
[0.56–
0.81]
1.03
[0.97–
1.10]
1.01
[0.92–
1.11]
aORa [99% CI] 1.00
[0.88–
1.12]
1.09
[0.98–
1.22]
1.17
[1.03–
1.33]
1.10
[1.01–
1.91]
0.96
[0.83–
1.10]
0.99
[0.92–
1.06]
1.09
[1.01–
1.18]
1.15
[1.08–
1.22]
0.88
[0.82–
0.93]
0.70
[0.58–
0.84]
1.01
[0.95–
1.08]
1.01
[0.92–
1.11]
Postpartum
haemorrhages
≥1000 ml, %
35,868
(6.00)
1088
(5.62)
1147
(5.17)
977
(6.19)
2283
(5.41)
1041
(5.99)
4610
(6.53)
3054
(5.85)
6155
(6.03)
7832
(5.79)
411
(3.72)
5430
(6.88)
1840
(5.95)
Crude OR [99% CI] 0.99
[0.91–
1.06]
0.90
[0.84–
0.97]
1.09
[1.01–
1.18]
0.95
[0.90–
0.998]
1.05
[0.97–
1.14]
1.16
[1.11–
1.20]
1.03
[0.98–
1.08]
1.06
[1.02–
1.10]
1.02
[0.98–
1.05]
0.64
[0.57–
0.72]
1.22
[1.17–
1.27]
1.05
[0.99–
1.11]
aORa [99% CI] 0.99
[0.92–
1.07]
0.92
[0.85–
0.99]
1.11
[1.02–
1.21]
0.94
[0.89–
0.995]
1.09
[0.998–
1.18]
1.14
[1.09–
1.19]
0.98
[0.93–
1.03]
1.04
[0.99–
1.08]
1.02
[0.99–
1.06]
0.66
[0.58–
0.74]
1.20
[1.15–
1.25]
1.04
[0.98–
1.10]
aOdds ratios, adjusted for parity, maternal age, ethnic background, socioeconomic status and urbanisation
bAntepartum and intrapartum stillbirth cases are excluded for analyses of Apgar score below 7 at 5 min
Percentage of missing data: 0.0% for antepartum and intrapartum stillbirth, 0.1% for neonatal mortality, 0.1% for Apgar score below 7 at 5 minutes, 1.4% for 3rd
and 4th degree perineal tear, 2.7% for postpartum haemorrhages > 1000 ml
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rates of paediatric involvement, leading to differences
in care and costs. Further research is required to
examine which medical and non-medical factors may
explain the large variations in pain medication and
involvement of a paediatrician.
Clinical practice is influenced by characteristics of the
care provider, such as age, educational background,
perceptions of risks, and views on childbirth [62–66].
Culture within the work environment may encourage
care providers to take similar decisions, and variations
are therefore not merely individual [67]. Differences in
perceptions and attitudes may result in differences in
local practice and guidelines. The fact that variations
were found between regions, even after adjustments for
maternal characteristics, suggests that there may be
cultural differences between regions, reflected in
differences in the views of care providers on childbirth
[63, 68, 69]. The large variation, in particular for pain
medication and involvement of a paediatrician, cannot
be explained by clinical variations only. Similarities in
variations in interventions that were found between
women in midwife-led and obstetrician-led care,
suggest similar practice by midwives and obstetricians
within regions. These similarities existed in interven-
tions with minor variation as well as in those with
considerable variation. The results of this study call
for implementation of evidence-based interventions,
and for investigation into indications for the use of
interventions in childbirth [10]. The Robson Classifi-
cation System could be used to explore subgroups of
women that account for the greatest variation [70].
Limited variation in some of the interventions in our
study may indicate consensus about its use. However,
variations may be greater between midwifery prac-
tices, hospitals, collaborations or care providers, than
between regions where variations between organisa-
tions and practitioners will have been averaged. In
further research, variations within the regions should
therefore be investigated.
Conclusions
The greatest variation was found for the type of pain
medication and the involvement of a paediatrician, and
the least for instrumental vaginal birth and intrapartum
CS rates. The rates of adverse outcomes were not lower
in regions with higher intervention rates. Care providers
should critically audit remarkable variations, since these
may be unwarranted. Variation may be explained to
some extent by a difference in the degree of implemen-
tation of national guidelines between regions. Further re-
search should therefore focus on variations in evidence-
based interventions and indications for the use of inter-
ventions in childbirth.
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